Related Experiment Video
Updated: May 19, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma
Justina McEvoy1, Anatoly Ulyanov, Rachel Brennan
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Abstract:
Retinoblastoma is a childhood cancer of the developing retina that begins in utero and is diagnosed in the first years of life. Biallelic RB1 gene inactivation is the initiating genetic lesion in retinoblastoma. The p53 gene is intact in human retinoblastoma but the pathway is believed to be suppressed by increased expression of MDM4 (MDMX) and MDM2. Here we quantify the expression of MDM4 and MDM2 mRNA and protein in human fetal retinae, primary retinoblastomas, retinoblastoma cell lines and several independent orthotopic retinoblastoma xenografts. We found that MDM4 is the major p53 antagonist expressed in retinoblastoma and in the developing human retina. We also discovered that MDM4 protein steady state levels are much higher in retinoblastoma than in human fetal retinae. This increase would not have been predicted based on the mRNA levels. We explored several possible post-transcriptional mechanisms that may contribute to the elevated levels of MDM4 protein. A proportion of MDM4 transcripts are alternatively spliced to produce protein products that are reported to be more stable and oncogenic. We also discovered that a microRNA predicted to target MDM4 (miR191) was downregulated in retinoblastoma relative to human fetal retinae and a subset of samples had somatic mutations that eliminated the miR-191 binding site in the MDM4 mRNA. Taken together, these data suggest that post-transcriptional mechanisms may contribute to stabilization of the MDM4 protein in retinoblastoma.
Insights
MDM4 protein, a key p53 antagonist, is elevated in retinoblastoma (childhood eye cancer) due to post-transcriptional mechanisms, not just mRNA levels. This finding offers new insights into retinoblastoma development.
Area of Science:
- Ophthalmology
- Oncology
- Molecular Biology
Background:
- Retinoblastoma is a childhood retinal cancer initiated by RB1 gene inactivation.
- The p53 pathway, crucial for tumor suppression, is often intact but suppressed in retinoblastoma.
- MDM4 (MDMX) and MDM2 are known p53 antagonists implicated in retinoblastoma pathogenesis.
Purpose of the Study:
- To quantify MDM4 and MDM2 mRNA and protein expression in retinoblastoma and developing retina.
- To investigate the mechanisms underlying elevated MDM4 protein levels in retinoblastoma.
- To explore the role of post-transcriptional regulation in retinoblastoma development.
Main Methods:
- Quantitative analysis of MDM4 and MDM2 mRNA and protein expression.
- Comparison of expression levels in human fetal retinae, retinoblastomas, cell lines, and xenografts.
- Investigation of alternative splicing, microRNA regulation (miR-191), and somatic mutations in MDM4.
Main Results:
- MDM4 is the primary p53 antagonist in retinoblastoma and fetal retina.
- MDM4 protein levels are significantly higher in retinoblastoma than in fetal retina, exceeding predictions based on mRNA levels.
- Post-transcriptional mechanisms, including alternative splicing and miR-191 downregulation/mutation, contribute to elevated MDM4 protein stability.
Conclusions:
- MDM4 protein stabilization via post-transcriptional mechanisms is a key feature of retinoblastoma.
- These findings highlight the importance of regulating MDM4 protein levels for controlling retinoblastoma.
- Understanding these mechanisms may reveal novel therapeutic targets for retinoblastoma.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...